Clinical Trial Update: The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes [NA]

View source ↗

Summary

A clinical trial is exploring whether endogenous GLP-1 modulates glucagon secretion in individuals with Type 1 diabetes mellitus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Asger Lund, MD | Conditions: Type 1 Diabetes | NA | Status: RECRUITING